BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7039940)

  • 1. A controlled clinical trial in advanced ovarian cancer.
    Adams M; Johansen KA; James KW; Rocker I
    Clin Radiol; 1982 Mar; 33(2):161-3. PubMed ID: 7039940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
    Aroney RS; Levi JA; Dalley DN
    Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single agent vs combination chemotherapy in the treatment of ovarian cancer.
    Barlow JJ; Piver MS
    Obstet Gynecol; 1977 May; 49(5):609-11. PubMed ID: 850579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
    Lele SB; Piver MS; Barlow JJ
    Obstet Gynecol; 1978 Jan; 51(1):101-4. PubMed ID: 619324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in advanced ovarian cancer.
    Smith JP; Rutledge FN
    Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma.
    Aabo K; Hald I; Hørbov S; Dombernowsky P; Hansen HH; Sørensen HM; Lundvall F; Nielsen NC; Sørensen BL
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):475-81. PubMed ID: 3891362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
    Young RC; Chabner BA; Hubbard SP; Canellos GP; DeVita VT
    Natl Cancer Inst Monogr; 1975 Oct; 42():145-8. PubMed ID: 825777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of advanced carcinoma of the bladder with combination chemotherapy.
    McGeorge A; Hart AJ; Rundle JS; McVie JG; Calman KC
    Br J Urol; 1982 Aug; 54(4):366-8. PubMed ID: 7052188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
    Edwards CL; Herson J; Gershenson DM; Copeland LJ; Wharton JT
    Gynecol Oncol; 1983 Apr; 15(2):261-77. PubMed ID: 6403413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
    Hreshchyshyn MM
    Natl Cancer Inst Monogr; 1975 Oct; 42():155-65. PubMed ID: 1234633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of cyclophosphamide, Adriamycin, and 5-fluorouracil with triethylenethiophosphoramide and methotrexate, both as sequential and as fixed rotational treatment in patients with advanced ovarian cancer.
    Bruckner HW; Dinse GE; Davis TE; Falkson G; Creech RH; Arseneau JC; Greenspan EM; Brodovsky HS; Pagano M; Hahn RG
    Cancer; 1985 Jan; 55(1):26-40. PubMed ID: 3917352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second trial drugs in ovarian cancer.
    Stanhope CR; Smith JP; Rutledge F
    Gynecol Oncol; 1977 Mar; 5(1):52-8. PubMed ID: 404216
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovarian cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy.
    Lewis GC; Blessing J
    Cancer; 1977 Jul; 40(1 Suppl):588-94. PubMed ID: 406985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.
    De Palo GM; De Lena M; Bonadonna G
    Cancer Treat Rep; 1977; 61(3):355-7. PubMed ID: 326402
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF).
    Brugarolas A; Lacave AJ; Ribas A; Buesa JM; Garcia Miralles MT
    Eur J Cancer (1965); 1979 Mar; 15(3):331-5. PubMed ID: 376316
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of ovarian cancer: past and present.
    Young RC
    Semin Oncol; 1975 Sep; 2(3):267-76. PubMed ID: 827024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of the ovarian carcinoma (author's transl)].
    Bruntsch U; Gallmeier WM
    Strahlentherapie; 1977 May; 153(5):325-30. PubMed ID: 406695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melphalan chemotherapy in advanced ovarian carcinoma.
    Piver MS; Barlow JJ; Yazigi R; Blumenson LE
    Obstet Gynecol; 1978 Mar; 51(3):352-6. PubMed ID: 628541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.